Bausch Health Companies (BHC) Cash from Investing Activities (2009 - 2026)

Bausch Health Companies has disclosed Cash from Investing Activities across 18 years of filings, most recently posting -$139.0 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$139.0 million, down 6.92% year-over-year; the trailing twelve-month figure through Mar 2026 was -$604.0 million (down 18.2% YoY), and the FY2025 annual result was -$595.0 million, down 31.06% from the prior year.
• Cash from Investing Activities came in at -$139.0 million for Q1 2026 at Bausch Health Companies, up from -$282.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$30.0 million in Q2 2023 to a low of -$1.9 billion in Q3 2023.
• The 5-year median for Cash from Investing Activities is -$100.0 million (2025), against an average of -$213.9 million.
• Across the five-year window, Cash from Investing Activities plunged 3464.15% in 2023 and jumped 94.6% in 2024, its largest moves.
• Bausch Health Companies' Cash from Investing Activities stood at -$136.0 million in 2022, then dropped by 8.82% to -$148.0 million in 2023, then sank by 35.14% to -$200.0 million in 2024, then slumped by 41.0% to -$282.0 million in 2025, then surged by 50.71% to -$139.0 million in 2026.
• The last three Cash from Investing Activities figures came in at -$139.0 million (Q1 2026), -$282.0 million (Q4 2025), and -$83.0 million (Q3 2025), per Business Quant data.